TABLE 1.
Baseline Characteristics at SLKT
| Variables at LT (n = 570) | Median (IQR) or n (%) |
|---|---|
| Recipient characteristics | |
| Age at LT, years | 58 (51–64) |
| Columbia | 47 (8.3) |
| Duke University | 43 (7.5) |
| Northwestern University | 281 (49.3) |
| University of California, San Francisco | 100 (17.5) |
| University of Michigan | 51 (9.0) |
| University of Washington | 48 (8.4) |
| Male | 361 (63) |
| Female | 209 (37) |
| White | 432 (75.8) |
| Black | 71 (12.5) |
| Other races | 67 (11.7) |
| Hepatitis C virus infection | 189 (33) |
| Alcohol-related cirrhosis | 131 (23) |
| NASH/cryptogenic cirrhosis | 112 (20) |
| Other etiologies | 138 (24) |
| AKI | 149 (26) |
| CKD | 257 (45) |
| Other | 164 (29) |
| Pre-LT dialysis or RRT | 220 (39) |
| Hypertension | 306 (54) |
| Diabetes mellitus | 237 (42) |
| BMI, kg/m2 | 27 (24–32) |
| RRI score | 7.57 (5.2–12.2) |
| MELD-NA score | 28 (23–34) |
| Donor and transplant characteristics | |
| Donor age, years | 36 (23–48) |
| DCD | 24 (4.2) |
| Donor, male | 318 (55.7) |
| Donor cause of death, cerebrovascular deaths | 382 (67) |
| KDPI score, n = 184 | 32 (15–66) |
| CIT, minutes | 360 (300–465) |
| WIT, minutes | 37.5 (25–60) |
| Tacrolimus | 541 (95) |
| Cyclosporine | 29 (5) |
| Induction, yes | 138 (24) |
| Kidney DGF | 133 (23.3) |
| Length of stay, transplant admission, days | 19 (9–33) |
| eGFR at last follow-up | 54 ml/minute per 1.73 m2 (33–65) |
| Time to last follow-up | 63.6 months (28.2–110.6) |